Fundz

Aro Biotherapeutics Co reported raising $5 Million in an initial SEC Form D filing, from an offering of $5 Million

PRIVATEJan 06, 2020

Amount Raised

$5 Million

$5 Million sold, per SEC Form D (first sale Jan 6, 2020)

Round Type

Venture

PhiladelphiaBiotechnologyHealthcare

Quick answer

Aro Biotherapeutics raised $5 Million in a funding round, dated January 6, 2020. Aro Biotherapeutics is based in Philadelphia, Pennsylvania, United States.

How much did Aro Biotherapeutics raise?
Aro Biotherapeutics raised $5 Million in a funding round on January 6, 2020.
What does Aro Biotherapeutics do?
Aro Biotherapeutics is a biotechnology company pioneering the development of tissue-targeted genetic medicines with a platform based on a proprietary protein technology called Centyrins.
Where is Aro Biotherapeutics based and how big is it?
Aro Biotherapeutics is based in Philadelphia, Pennsylvania, United States. Fundz records about 49 employees.
Who are the decision-makers at Aro Biotherapeutics?
Fundz holds 1 contact at Aro Biotherapeutics, including the Executive Officer. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Healthcare and Biotechnology around the same time

Companies in the same sectors as Aro Biotherapeutics that raised within 45 days of this round, from Fundz verified event records.

  • Marina Biotech, Inc. raised $500K (Seed) on February 19, 2020.
  • DermTech, Inc. raised $182K (Pre-Seed) on February 19, 2020.
  • TearClear Corp. raised $2.8M (Seed) on February 14, 2020.
  • JenaValve raised $35M on February 13, 2020.
  • Helaina Inc raised $360K (Seed) on February 11, 2020.
  • PRECIGEN, INC. raised $35M on February 11, 2020.

Who to call at Aro Biotherapeutics, and when

A new round usually means Aro Biotherapeutics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Aro Biotherapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Aro Biotherapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Aro Biotherapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Aro Biotherapeutics

Location

3675 MARKET STREET, SUITE 200

Philadelphia, Pennsylvania, United States

About

Aro Biotherapeutics is a biotechnology company pioneering the development of tissue-targeted genetic medicines with a platform based on a proprietary protein technology called Centyrins. The company is developing a wholly-owned pipeline of Centyrin-based therapeutic candidates and is working with industry partners to leverage Centyrins for tissue-specific targeting of therapeutics for a diverse set of diseases.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Aro Biotherapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsScott G., Executive Officer hidden hidden hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Aro Biotherapeutics's next move

See what Strategic adds

Aro Biotherapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.